Company news
Microbix Biosystems Inc. news in 2006
Microbix Biosystems Inc.'s news releases, calls and decks from 2006, newest first.
Microbix Announces Fiscal 2006 Results: Year Highlighted By Sales Growth, Product And Infrastructure Investment, And Independent Confirmation Of Its Flu Vaccine Technology
December 15, 2006
Microbix Updates Plans For Urokinase With Angiogen LLC
November 2, 2006
Financing Announced For Ongoing Development Of Large Market Pipeline
October 17, 2006
Microbix Completes Continuous Disclosure Review With Ontario Securities Commission
September 7, 2006
Microbix' third quarter results reflect continued significant investment in its three proprietary, large-market products
August 14, 2006
Microbix Establishes Key Global Distribution Agreements for its SST(TM) Sperm Sexing Technology for the Dairy, Beef and Swine Industries
July 11, 2006
Microbix and Angiogen seek funding for clinical trials; remission of cancer already observed in early studies; patented therapy destroys tumors by 'starving them' of the nutrients to survive and grow
June 27, 2006
Independent Laboratory Confirms that Microbix' Proprietary Vaccine Technology Significantly Boosts Production of Human Flu Virus From Eggs
June 1, 2006
Powered by strong sales of virology products, Microbix continues to move forward in the development of its proprietary technologies
May 15, 2006
Now there's something you CAN do to prepare for a flu pandemic: Pandemic Response Plan and ToolKit(TM) developed by Microbix now available to consumers and businesses
April 20, 2006
Microbix enters agreement with Angiogen to commercialize a proprietary technology that uses urokinase product for treating cancer
April 4, 2006
Interim Results of Independent Evaluation Confirm That Microbix' Flu Vaccine Technology Works
March 14, 2006
Microbix announces core product sales increase in first quarter, development of new high-value business opportunities
February 15, 2006
Microbix completes financing for its new state-of-the-art drug manufacturing facility in Toronto
February 9, 2006
Microbix takes over production of urokinase, and is currently negotiating the exclusive right to manufacture the drug for a new proprietary use
January 31, 2006